Similar Search Results

Special FDA designations for drug development : orphan, fast track, accelerated approval, priority review, and breakthrough therapy

Michaeli, Daniel; Michaeli, Christoph T.; Albers, Sebastian - In: The European journal of health economics 25 (2024) 6, pp. 979-997

Persistent link: https://www.econbiz.de/10014633366

Pharmaceutical innovation : revolutionizing human health

Landau, Ralph (ed.); Achilladelis, Basil (contributor); … - 1999

Persistent link: https://www.econbiz.de/10001423161

The $800 million pill : the truth behind the cost of new drugs

Goozner, Merrill - 2004

Persistent link: https://www.econbiz.de/10001803092

How does uncertainty resolution affect VC syndication?

Altintig, Z. Ayca; Chiu, Hsin Hui; Goktan, M. Sinan - In: Financial management 42 (2013) 3, pp. 611-646

Persistent link: https://www.econbiz.de/10010211230

The impact of the entry of biosimilars : evidence from Europe

Scott Morton, Fiona; Stern, Ariel D.; Stern, Scott - 2017

Persistent link: https://www.econbiz.de/10011708133

Evaluating the US pharmaceutical patent policy

Izhak, Olena; Saxell, Tanja; Takalo, Tuomas - 2021

The debate on whether COVID-19 vaccine patents are slowing down the pace of vaccination and the recovery from the crisis has brought the optimal design of pharmaceutical patent policy to the fore. In this paper we evaluate patent policy in the US pharmaceutical industry. We estimate the effect...